e-Drug3D

2074

TAURURSODIOL

DISCONTINUED


INN
TAURURSODIOL

cas 14605-22-2
CLASS

NERVOUS SYSTEM
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
AMBIPHILIC BILE ACID
TAURINE CONJUGATE OF URSODIOL

ROUTE (list)

ORAL

ATC code

PK parameters

Tmax 4.5 HOUR
PPB 98 PERCENT

Solubility

SPARINGLY SOLUBLE IN WATER


Target

-

PDB
5DLV (CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA))

Ligand code = 5D5 (link to the list of PDB complexes)

Download experimental 3D coordinates of 5D5 with added hydrogens

DrugCentral

Unknown

Download SDF file Ethanesulfonic acid, 2-[[(3alpha,5beta,7beta)-3,7-dihydroxy-24-oxocholan-24-yl]amino]- (9CI, ACI)

Formula:
C26H45NO6S

Calculated chemical properties:

MW 499.70
NB_atoms 34
XLogP 3.40
PSA 126.589
NB_HD 4
NB_HA 7
fsp3 0.96
Lipinski(0=no;1=yes) 1

FDA
NDA 216660 (label) INN (SODIUM PHENYLBUTYRATE ; TAURURSODIOL) RELYVRIO (AMYLYX) APPROVAL= AP YEAR= 2022 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL